Continued interdisciplinary research and technological innovation will be essential to fully harness the potential of iPSC-derived insulin target cells for disease modeling, personalized medicine, and regenerative therapies, ultimately improving outcomes for individuals affected by diabetes worldwide. Here, INS is linked to diabetes mellitus.